🤖 AI Summary
This work addresses the cold-start problem in biomedical knowledge graphs, where out-of-graph molecules—provided only as SMILES strings—cannot be linked or reasoned over. To tackle this, the authors propose MolBioKG, a two-tier system that first constructs a static index of 2.74 million molecules based on scaffolds, fragments, functional groups, and molecular fingerprints, enabling multi-resolution structural anchoring and static multi-anchor retrieval via Reciprocal Rank Fusion. Building upon this, an adaptive, interpretable knowledge graph traversal is performed using a tool-augmented large language model (Adapt-KG). Requiring no task-specific training, the approach significantly improves multi-hop reasoning performance, raising Hits@10 from 0.585 to 0.876, and boosts target recall for out-of-graph molecules from 0.145 to 0.269, while ensuring predictions are grounded in structural anchors and traceable evidence.
📝 Abstract
Biomedical knowledge graphs (KGs) accelerate drug discovery, but standard pipelines assume query molecules already exist as graph entities, leaving unregistered molecules disconnected. We address this cold-start challenge, termed the out-of-graph molecule problem, by introducing MolBioKG. This two-layer system grounds unseen molecules in biomedical evidence via multi-resolution structural anchoring. It connects an index of 2.74 million molecules (represented by scaffolds, fragments, functional groups, and fingerprints) to a 9.6-million-edge KG. Given only a SMILES string, MolBioKG retrieves structurally related graph entities and traverses their biomedical neighborhoods without task-specific training. It features two inference mechanisms: static multi-anchor retrieval using Reciprocal Rank Fusion, and Adapt-KG, a tool-using LLM policy for adaptive traversal. Evaluated across in-graph link recovery, complex multi-hop reasoning, and out-of-graph generalization, MolBioKG outperforms strong baselines. Notably, it raises Hits@10 from 0.585 to 0.876 in multi-hop reasoning and out-of-graph target recall from 0.145 to 0.269, all while ensuring predictions retain traceable structural anchors and source-attributed KG evidence.